Geers Jolien, Manral Nipun, Razipour Aryabod, Park Caroline, Tomasino Guadalupe Flores, Xing Emily, Grodecki Kajetan, Kwiecinski Jacek, Pawade Tania, Doris Mhairi K, Bing Rong, White Audrey C, Droogmans Steven, Cosyns Bernard, Slomka Piotr J, Newby David E, Dweck Marc R, Dey Damini
Biomedical Imaging Research Institute, department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Department of Cardiology, Centrum voor Hart- en Vaatziekten (CHVZ), Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussel, Belgium.
Heart. 2025 Jun 26;111(14):686-694. doi: 10.1136/heartjnl-2024-324925.
Epicardial adipose tissue represents a metabolically active visceral fat depot that is in direct contact with the left ventricular myocardium. While it is associated with coronary artery disease, little is known regarding its role in aortic stenosis. We sought to investigate the association of epicardial adipose tissue with aortic stenosis severity and progression, myocardial remodelling and function, and mortality in asymptomatic patients with aortic stenosis.
In a post hoc analysis of 124 patients with asymptomatic mild-to-severe aortic stenosis participating in a prospective clinical trial, baseline epicardial adipose tissue was quantified on CT angiography using fully automated deep learning-enabled software. Aortic stenosis disease severity was assessed at baseline and 1 year. The primary endpoint was all-cause mortality.
Neither epicardial adipose tissue volume nor attenuation correlated with aortic stenosis severity or subsequent disease progression as assessed by echocardiography or CT (p>0.05 for all). Epicardial adipose tissue volume correlated with plasma cardiac troponin concentration (r=0.23, p=0.009), left ventricular mass (r=0.46, p<0.001), ejection fraction (r=-0.28, p=0.002), global longitudinal strain (r=0.28, p=0.017), and left atrial volume (r=0.39, p<0.001). During the median follow-up of 48 (IQR 26-73) months, a total of 23 (18%) patients died. In multivariable analysis, both epicardial adipose tissue volume (HR 1.82, 95% CI 1.10 to 3.03; p=0.021) and plasma cardiac troponin concentration (HR 1.47, 95% CI 1.13 to 1.90; p=0.004) were associated with all-cause mortality, after adjustment for age, body mass index and left ventricular ejection fraction. Patients with epicardial adipose tissue volume >90 mm had 3-4 times higher risk of death (adjusted HR 3.74, 95% CI 1.08 to 12.96; p=0.037).
Epicardial adipose tissue volume does not associate with aortic stenosis severity or its progression but does correlate with blood and imaging biomarkers of impaired myocardial health. The latter may explain the association of epicardial adipose tissue volume with an increased risk of all-cause mortality in patients with asymptomatic aortic stenosis.
gov (NCT02132026).
心外膜脂肪组织是一种代谢活跃的内脏脂肪库,与左心室心肌直接接触。虽然它与冠状动脉疾病有关,但关于其在主动脉瓣狭窄中的作用知之甚少。我们试图研究心外膜脂肪组织与无症状主动脉瓣狭窄患者的主动脉瓣狭窄严重程度及进展、心肌重塑与功能以及死亡率之间的关联。
在一项对124例无症状轻至重度主动脉瓣狭窄患者进行的前瞻性临床试验的事后分析中,使用完全自动化的深度学习软件在CT血管造影上对基线心外膜脂肪组织进行定量。在基线和1年时评估主动脉瓣狭窄疾病的严重程度。主要终点是全因死亡率。
无论是心外膜脂肪组织体积还是衰减程度,与通过超声心动图或CT评估的主动脉瓣狭窄严重程度或随后的疾病进展均无相关性(所有p>0.05)。心外膜脂肪组织体积与血浆心肌肌钙蛋白浓度(r=0.23,p=0.009)、左心室质量(r=0.46,p<0.001)、射血分数(r=-0.28,p=0.002)、整体纵向应变(r=0.28,p=0.017)以及左心房容积(r=0.39,p<0.001)相关。在中位随访48(四分位间距26 - 73)个月期间,共有23例(18%)患者死亡。在多变量分析中,调整年龄、体重指数和左心室射血分数后,心外膜脂肪组织体积(HR 1.82,95%CI 1.10至3.03;p=0.021)和血浆心肌肌钙蛋白浓度(HR 1.47,95%CI 1.13至1.90;p=0.004)均与全因死亡率相关。心外膜脂肪组织体积>90mm的患者死亡风险高3 - 4倍(调整后HR 3.74,95%CI 1.08至12.96;p=0.037)。
心外膜脂肪组织体积与主动脉瓣狭窄严重程度及其进展无关,但与心肌健康受损的血液和影像学生物标志物相关。后者可能解释了心外膜脂肪组织体积与无症状主动脉瓣狭窄患者全因死亡风险增加之间的关联。
美国国立医学图书馆临床试验注册库(NCT02132026)